Related Experiment Video
Updated: Oct 24, 2025

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
How changes in dopamine D2 receptor levels alter striatal circuit function and motivation
Eleanor H Simpson1,2, Eduardo F Gallo3, Peter D Balsam4,5,6,7
1Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY, USA. es534@cumc.columbia.edu.
Schizophrenia may stem from dopamine D2 receptor overstimulation. Mouse models reveal these receptors play complex, cell-specific roles in motivated behavior, impacting schizophrenia symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Molecular Biology
Background:
- Schizophrenia etiology linked to dopamine receptor overstimulation over 50 years ago.
- Striatal dopamine D2 receptors are implicated in positive and negative symptoms.
- Dopamine D2 receptors are the primary target for antipsychotic medications.
Purpose of the Study:
- To review the locations and signaling of dopamine D2 receptors.
- To summarize findings from mouse models with altered D2 receptor levels.
- To analyze the impact on striatal circuits and motivated behavior.
Main Methods:
- Review of existing literature on dopamine D2 receptor function.
- Analysis of data from genetically modified mouse models.
- Examination of behavioral, electrophysiological, and anatomical outcomes.
Main Results:
- Dopamine D2 receptors have distinct roles in different cell types and developmental stages.
- Perturbations in D2 receptor levels affect striatal circuit function.
- Altered D2 receptor expression impacts motivated behavior, a key negative symptom.
Conclusions:
- Dopamine D2 receptors exhibit complex, context-dependent regulation of motivated behavior.
- Understanding these distinct roles is crucial for developing targeted schizophrenia therapies.
- Further research into D2 receptor regulation may yield novel treatment strategies.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Affecting Neurotransmitter Release or Uptake
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

